WallStreetZenWallStreetZen

NASDAQ: COLL
Collegium Pharmaceutical Inc Stock Ownership - Who owns Collegium Pharmaceutical?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Collegium Pharmaceutical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Scott DreyerEVP Chief Commercial Officer2025-12-086,475$48.66
$315.09kSell
Scott DreyerEVP Chief Commercial Officer2025-12-0811,125$47.89
$532.77kSell
Scott DreyerEVP Chief Commercial Officer2025-12-0817,600$15.90
$279.84kBuy
Rita J. BalicegordonDirector2025-12-053,650$47.03
$171.67kSell
John A. FallonDirector2025-11-1234,853$47.21
$1.65MSell
Vikram KarnaniPresident and CEO2025-11-128,983$47.35
$425.35kSell
John A. FallonDirector2025-11-1215,000$16.49
$247.35kBuy
John A. FallonDirector2025-11-1219,853$9.33
$185.23kBuy
Colleen TupperEVP Chief Financial Officer2025-11-0625,142$40.38
$1.02MSell
Colleen TupperEVP Chief Financial Officer2025-11-064,858$41.28
$200.52kSell

1 of 5

COLL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COLL insiders and whales buy or sell their stock.

COLL Shareholders

What type of owners hold Collegium Pharmaceutical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David Hirsch20.37%6,438,798$305.91MInsider
Rubric Capital Management LP19.90%6,290,486$298.86MInsider
Longitude Capital Partners LLC17.85%5,643,684$268.13MInsider
Blackrock Inc16.38%5,178,044$246.01MInstitution
Skyline Venture Partners V LP16.13%5,099,832$242.29MInsider
Rubric Capital Management LP8.94%2,826,498$134.29MInstitution
Eventide Asset Management LLC7.56%2,390,912$113.59MInstitution
Vanguard Group Inc7.04%2,226,378$105.78MInstitution
Yasunori Kaneko6.80%2,150,186$102.16MInsider
Frazier Healthcare VI LP5.97%1,887,332$89.67MInsider

1 of 3

COLL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COLL51.95%48.05%Net SellingNet Selling
ALVO5.08%0.00%
PAHC43.61%56.39%Net SellingNet Selling
EVO5.56%0.00%
AMPH48.29%51.71%Net BuyingNet Selling
View Top Pharmaceutical Stocks

Collegium Pharmaceutical Stock Ownership FAQ

Who owns Collegium Pharmaceutical?

Collegium Pharmaceutical (NASDAQ: COLL) is owned by 116.93% institutional shareholders, 108.16% Collegium Pharmaceutical insiders, and 0.00% retail investors. David Hirsch is the largest individual Collegium Pharmaceutical shareholder, owning 6.44M shares representing 20.37% of the company. David Hirsch's Collegium Pharmaceutical shares are currently valued at $310.22M.

If you're new to stock investing, here's how to buy Collegium Pharmaceutical stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.